Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.
Myostatin (Mstn) is a secreted growth factor expressed in skeletal muscle and adipose tissue that negatively regulates skeletal muscle mass. Mstn(-/-) mice have a dramatic increase in muscle mass, reduction in fat mass, and resistance to diet-induced and genetic obesity. To determine how Mstn deleti...
Main Authors: | Tingqing Guo, William Jou, Tatyana Chanturiya, Jennifer Portas, Oksana Gavrilova, Alexandra C McPherron |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2654157?pdf=render |
Similar Items
-
Myostatin inhibition improves hyperglycemia and hyperphagia in lipodystrophic mice
by: Guo Tingqing, et al.
Published: (2012-06-01) -
Inhibition of myostatin signaling increases glucose in insulin-deficient diabetic mice
by: Guo Tingqing, et al.
Published: (2012-06-01) -
Redundancy of myostatin and growth/differentiation factor 11 function
by: Lee Se-Jin, et al.
Published: (2009-03-01) -
Effects of serotonin on skeletal muscle growth
by: Murphy Dennis L, et al.
Published: (2012-06-01) -
Brain insulin sensitivity is linked to adiposity and body fat distribution
by: Stephanie Kullmann, et al.
Published: (2020-04-01)